Stocksigma LogoStocksigma Logo

Vijaya Diagnostic Centre Reports Robust Q2 FY27 Results with 37.4% YoY PAT Growth

Vijaya Diagnostic Centre delivered strong Q2 FY27 performance, with revenue from operations growing 26.7% YoY to INR 2,554 Mn, driven by a 16.5% YoY rise

Vijaya Diagnostic Centre Reports Robust Q2 FY27 Results with 37.4% YoY PAT Growth

Vijaya Diagnostic Centre Ltd 路 Investor Presentation 路 04 Nov 2026, 2:03 am

Vijaya Diagnostic Centre Reports Robust Q2 FY27 Results with 37.4% YoY PAT Growth Vijaya Diagnostic Centre delivered strong Q2 FY27 performance, with revenue from operations growing 26.7% YoY to INR 2,554 Mn, driven by a 16.5% YoY rise in test volumes to 4.98 Mn and 14.5% footfall growth. EBITDA increased 37.8% YoY to INR 1,128 Mn with margins expanding 355 bps to 44.1%. PAT surged 37.4% YoY to INR 595 Mn. The B2C segment maintained a 92% revenue share. Strategically, the company expanded into the North-East by signing a BTA to acquire Arya Wellness Centre for INR 462 Mn.

Original exchange filing (PDF)

More announcements from Vijaya Diagnostic Centre Ltd

All Vijaya Diagnostic Centre Ltd announcements